A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference28 articles.
1. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA;Davis;Lancet,1990
2. Estimates of the worldwide incidence of eighteen major cancers in 1985;Parkin;Int J Cancer,1993
3. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL;Pfreundschuh;Blood,2004
4. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL;Pfreundschuh;Blood,2004
5. Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease;Diehl;N Engl J Med,2003
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients;Australasian Journal of Dermatology;2014-12-13
2. Gamma-delta T-cell Lymphoma with CNS Involvement Presenting with Proptosis: A Case Study Workup, Treatment and Prognosis;Orbit;2012-10
3. Gemcitabine and vinorelbine chemotherapy for refractory or relapsing aggressive non-Hodgkin lymphoma;Hematological Oncology;2012-03-16
4. Use of rHuG-CSF in New Chemotherapy Strategies;Twenty Years of G-CSF;2011-11-15
5. Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome;Biology of Blood and Marrow Transplantation;2011-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3